Utah Medical Products Inc (UTMD)
EBITDA Margin
40.75%
TTM · Period ending:
UTMD EBITDA Margin
Latest reported40.75%period ending
Latest reported40.75%period ending
UTMD TTM EBITDA Margin (9.21% → 40.75%)
TTM ebitda margin
High-resolution chart · PNG
UTMD ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 40.8384% | |
| 39.9852% | |
| 38.8211% | |
| 38.1489% | |
| 37.5617% | |
| 36.4926% | |
| 35.5726% | |
| 34.8123% | |
| 33.91% | |
| 32.7465% | |
| 32.0144% | |
| 30.292% | |
| 29.7794% | |
| 29.4118% | |
| 28.8066% | |
| 32.0463% | |
| 33.564% | |
| 34.8083% | |
| 34.8837% | |
| 33.7408% | |
| 32.6923% | |
| 31.7536% | |
| 31.6667% | |
| 30.5085% | |
| 29.803% | |
| 29% | |
| 28.5354% | |
| 26.4249% | |
| 26.3158% | |
| 27.0053% | |
| 26.7568% | |
| 28.4574% | |
| 29.5213% | |
| 28.6486% | |
| 28.5319% | |
| 29.5652% | |
| 28.7879% | |
| 28.754% | |
| 28.6195% | |
| 27.5261% | |
| 27.1062% | |
| 28.2353% | |
| 27.9167% | |
| 28.5714% | |
| 28.2927% | |
| 25.6545% | |
| 41.8994% | |
| -6.5089% | |
| 6.962% | |
| 22.2973% | |
| 14.8148% | |
| 38.9381% | |
| 28.866% | |
| 17.8571% | |
| 9.2105% |